February 14, 2018 / 1:36 AM / in 8 months

BRIEF-Celltrion Receives EU Approval For Trastuzumab Biosimilar

Celltrion Inc:

* CELLTRION RECEIVES EU APPROVAL FOR TRASTUZUMAB BIOSIMILAR

* CELLTRION-DECISION BY EU MEANS HERZUMA IS APPROVED FOR MARKETING IN 28 MEMBER STATES OF EU, IN ADDITION TO NORWAY, LIECHTENSTEIN AND ICELAND Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below